hCD19 CAR-T cells
/ Affiliated Hospital of Xuzhou Medical University
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 27, 2024
Expression of VISTA regulated via IFN-γ governs endogenous T-cell function and exhibits correlation with the efficacy of CD19 CAR-T cell treated B-malignant mice.
(PubMed, J Immunother Cancer)
- "Our findings confirm that endogenous T-cell activation and functionality are regulated by VISTA, which is associated with the therapeutic efficiency of CAR-T and provides a promising therapeutic strategy for relapse cases in CAR-T therapy."
CAR T-Cell Therapy • IO biomarker • Journal • Preclinical • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Lymphoma • Melanoma • Oncology • Solid Tumor • CD4 • CD8 • IFNG • VSIR
April 05, 2024
Impact of tocilizumab on anti-CD19 chimeric antigen receptor T-cell therapy in B-cell acute lymphoblastic leukemia.
(PubMed, Cancer)
- "Tocilizumab does not affect the efficacy of CAR T cells but may increase the likelihood of ICANS."
CAR T-Cell Therapy • Journal • Acute Lymphocytic Leukemia • B Acute Lymphoblastic Leukemia • Hematological Malignancies • Leukemia • Oncology
1 to 2
Of
2
Go to page
1